|
V76486
|
SPC5001 |
|
SPC5001 is a locked nucleic acid (LNA) modified antisense oligonucleotide (ASO) complementary to human PCSK9 (preprotein convertase subtilisin/kexin type 9) mRNA. |
|
V76485
|
SPEN-IN-1 |
|
SPEN-IN-1 (compound X1) is an inhibitor (blocker/antagonist) of protein factor SPEN with a Kd of 47 nM. |
|
V76483
|
SPOP-IN-6b dihydrochloride |
|
SPOP-IN-6b diHCl is a potent inhibitor of plaque-type POZ protein (SPOP) with IC50 of 3.58 μM. |
|
V81430
|
Squalene synthase-IN-1 |
|
Squalene synthase-IN-1 (compound 1) is a potent hypolipidemic agent that works by inhibiting Squalene Synthase. |
|
V81434
|
SRP-5051 sodium (Vesleteplirsen sodium) |
|
SRP-5051 is a next-generation peptide phosphodiamide morpholine oligomer (PPMO). |
|
V76480
|
SSM3 tetraTFA hydrate |
|
SSM3 tetraTFA hydrate is a potent synthetic furin inhibitor (antagonist) with EC50 and Ki of 54 nM and 12 nM respectively. |
|
V80003
|
Steroid sulfatase-IN-5 |
|
Steroid sulfatase-IN-5 (compound 10b) is a steroid sulfatase (STS) inhibitor (IC50= 0.32 nM). |
|
V80019
|
Steroid sulfatase-IN-6 |
|
Steroid sulfatase-IN-6 (Compound 10c) is an irreversible inhibitor of steroid sulfatase (STS). |
|
V81447
|
Steroid sulfatase-IN-7 |
|
Steroid sulfatase-IN-7 is an irreversible steroid sulfatase (STS) inhibitor (antagonist) with IC50 of 0.05 nM for human placental STS and may be utilized in cancer research. |
|
V79760
|
Steroid sulfatase/17β-HSD1-IN-5 |
|
Steroid sulfatase/17β-HSD1-IN-5 is an irreversible inhibitor of steroid sulfatase (STS) and a reversible and selective inhibitor of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1). |
|
V81460
|
Sucistil |
|
Sucistil is a bioactive compound. |
|
V79523
|
Sucunamostat hydrate (SCO-792) |
|
Sucunamostat (SCO-792) hydrate is an orally bioactive and reversible enteropeptidase inhibitor. |
|
V76471
|
Sucunamostat hydrochloride (SCO-792 hydrochloride) |
|
Sucunamostat (SCO-792) HCl is an orally bioactive and reversible enteropeptidase inhibitor. |
|
V81463
|
Suffruticosol A |
|
Suffruticosol A is a neuro-protection agent capable of restoring scopolamine-induced cellular neurodegenerative damage. |
|
V80097
|
Sulazepam-d5 |
|
Sulazepam-d5 is a deuterium labelled form of Sulazepam. |
|
V81465
|
Sulfo DBCO-PEG3-NHS ester |
|
Sulfo DBCO-PEG3-NHS ester is a reagent for click chemistry bearing an azide (N3) moiety. |
|
V81482
|
SW1 aptamer sodium |
|
SW1 aptamer sodium is a high-affinity DNA aptamer (Kd: 123.62 nM) that targets liver cancer SMMC-7721 cells and targets intracellular components in the nucleus. |
|
V81483
|
SW1-A aptamer sodium |
|
SW1-A aptamer sodium is an optimized aptamer based on SW1 aptamer, specifically targeting liver cancer SMMC-7721 cells (Kd: 133.73 nM). |
|
V81487
|
SYL3C aptamer sodium |
|
SYL3C aptamer sodium is a DNA aptamer that targets epithelial cell adhesion molecule (EpCAM) on the surface of cancer cells. |
|
V81488
|
SYNTi |
|
SYNTi is a PDZ domain inhibitor targeting the syndecan/syntenin protein-protein interaction. |